In vitro and in vivo protective effect of orphenadrine on glutamate neurotoxicity

This publication has 22 references indexed in Scilit:

• U-83836E prevents kainic acid-induced neuronal damage
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1998
• Modulation of neuronal mitochondrial membrane potential by the NMDA receptor: role of arachidonic acid
  Brain Research, 1997
• Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies
  Neuroscience & Biobehavioral Reviews, 1997
• Glutamate and Parkinson’s disease
  Molecular Neurobiology, 1996
• Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function
  Neuron, 1995
• Regional pattern of increased ω3 (peripheral type benzodiazepine) binding site densities in the rat brain induced by systemic injection of kainic acid
  Neuroscience Letters, 1991
• The quantification of brain lesions with anω3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration
  Brain Research, 1990
• Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage
  Brain Research, 1987
• Simple and rapid GLC method for the determination of orphenadrine in human plasma
  Biomedical Chromatography, 1987
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976